Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live

United States — Food and Drug Administration & United States — National Cancer Institute

8 shared events · Importance 3 · Last updated Jun 16, 2026

Importance
3
Shared Events
8
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
56
Regulatory
United States — Food and Drug Administration: Its advisory panel endorsed the test, but the agency still must make the final approval decision and has flagged efficacy concerns.
United States — National Cancer Institute: Its experts and officials questioned the test's early-detection performance and it funds research on multi-cancer detection feasibility.
Sep 23, 2026 · 18 articles
40
Regulatory
United States — Food and Drug Administration: The United States — Food and Drug Administration>>> granted Priority Review for Roche>>>'s Atezolizumab, indicating a potential new treatment option for colon cancer patients.
United States — National Cancer Institute: The United States — National Cancer Institute>>> sponsored the ATOMIC study, which provided the data for Roche>>>'s sBLA filing.
Jun 11, 2026 · 6 articles
40
Tech
United States — Food and Drug Administration: The FDA is the regulatory authority that must approve the vaccine. Approval could come as soon as 2027, but the agency's review process and potential political interference from the administration could affect the timeline.
United States — National Cancer Institute: The United States — National Cancer Institute provided data on melanoma prevalence and is involved in cancer research. The trial's success could influence its research priorities and funding.
Aug 19, 2026 · 126 articles
39
Regulatory
United States — Food and Drug Administration: The FDA granted expedited approval to daraxonrasib, marking a regulatory milestone and demonstrating its commitment to accelerating cancer treatments. The approval was issued 6.5 months ahead of schedule, reflecting the agency's priority review process.
United States — National Cancer Institute: The United States — National Cancer Institute provided data on pancreatic cancer cases, contributing to the context of the approval.
Aug 26, 2026 · 92 articles
3
Business
United States — Food and Drug Administration: The FDA has cleared several of Ascentage Pharma's Phase III trials, but this event does not directly involve the FDA.
United States — National Cancer Institute: NCI is a research partner of Ascentage Pharma, but this event does not directly involve NCI.
Jul 26, 2026 · 6 articles
0
Business
United States — National Cancer Institute: The United States — National Cancer Institute is sponsoring trials for iadademstat in various hematologic malignancies and solid tumors under a Cooperative Research and Development Agreement with Oryzon Genomics.
May 14, 2026 · 6 articles
0
Tech
United States — National Cancer Institute: The United States — National Cancer Institute is where Dr. Steven Rosenberg has served as Chief of the Surgery Branch since 1974, providing the institutional support for his foundational work in cancer immunotherapy.
Jun 16, 2026 · 8 articles
0
Tech
United States — National Cancer Institute: The United States — National Cancer Institute partially funded the study, supporting critical cancer research.
May 19, 2026 · 6 articles
ERGEN INTELLIGENCE
Explore this relationship live

Track how United States — Food and Drug Administration and United States — National Cancer Institute interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.